Clinical trial
A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal.
NCT00287469 · U.S. Army Medical Research and Development Command, U.S. Fed · Completed
Key facts
| NCT number | NCT00287469 |
|---|---|
| Title | A Safety and Efficacy Study of the Hepatitis E Vaccine in Nepal. |
| Official title | A Phase II, Prospective, Randomized, Double-blind, Placebo Controlled, Field Efficacy Trial of a Candidate Hepatitis E Vaccine in Nepal. |
| Lead sponsor | U.S. Army Medical Research and Development Command, U.S. Fed |
| Collaborators | GlaxoSmithKline Industry National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis |
| Intervention type | Biological, Other |
| Interventions | Hepatitis E vaccine, recombinant (Sar 56 kDa), Placebo |
| Enrollment | 2,000 |
| Start date | Jul 9, 2001 |
| Primary completion | Jan 19, 2004 |
| Completion | Jan 1, 2005 |
| First posted | Feb 6, 2006 |
| Last update posted | May 29, 2019 |
| Countries | Nepal |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: